J
Jesús Planagumà
Researcher at Hebron University
Publications - 9
Citations - 402
Jesús Planagumà is an academic researcher from Hebron University. The author has contributed to research in topics: Tumor progression & Cancer. The author has an hindex of 8, co-authored 9 publications receiving 376 citations. Previous affiliations of Jesús Planagumà include Autonomous University of Barcelona & University of Helsinki.
Papers
More filters
Journal ArticleDOI
A Differential Gene Expression Profile Reveals Overexpression of RUNX1/AML1 in Invasive Endometrioid Carcinoma
Jesús Planagumà,María Díaz-Fuertes,Antonio Gil-Moreno,Miguel Abal,Marta Monge,Ángel García,Teresa Baró,Timothy M. Thomson,Jordi Xercavins,Francesc Alameda,Jaume Reventós +10 more
TL;DR: Tissue array immunohistochemistry showed that RUNX1/AML1 up-regulation correlates to the process of tumorigenesis, from normal atrophic endometrium to simple and complex hyperplasia and then, on to carcinoma.
Journal ArticleDOI
Tissue plasminogen activator is required for the growth, invasion, and angiogenesis of pancreatic tumor cells
TL;DR: T-PA, in addition to its known role in invasion, plays other critical roles in pancreas tumor progression, stimulating cancer cell proliferation and tumor-associated angiogenesis.
Journal ArticleDOI
Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinoma
Jesús Planagumà,Jesús Planagumà,Mikko Liljeström,Francesc Alameda,Ralf Bützow,Ismo Virtanen,J. Reventós,Mika Hukkanen +7 more
TL;DR: Results indicate concurrent mechanisms in expression of MMP-2 and -9, RUNX1/AML1 and ETV5/ERM, and several of the basement membrane components, which are likely to associate with the invasive stage of EEC and OEC.
Journal ArticleDOI
ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer.
Marta Monge,Eva Colas,Andreas Doll,Marta de la Cuesta González,Antonio Gil-Moreno,Jesús Planagumà,Maite Quiles,Maria Antonia Arbos,Ángel García,Josep Castellví,Marta Llauradó,Marina Rigau,Hafid Alazzouzi,Jordi Xercavins,Francesc Alameda,Jaume Reventós,Miguel Abal +16 more
TL;DR: It is proposed that in EEC, ERM/ETV5 acts through MMP-2 gelatinolytic activity to confer invasive capabilities, associated with an initial switch to myometrial infiltration.
Journal ArticleDOI
Molecular pathology of endometrial carcinoma: transcriptional signature in endometrioid tumors.
Miguel Abal,Jesús Planagumà,Antonio Gil-Moreno,Marta Monge,Martiño Piñeiro González,Teresa Baró,Alejandro Javier García,Josep Castellví,S. Ramón y Cajal,Jordi Xercavins,F. Alameda,J. Reventós +11 more
TL;DR: Genes involved in the mitotic checkpoint as a major mechanism of carcinogenesis in non-endometrioid endometrial cancer, or altered genes associated with the initial steps of myometrial infiltration in endometriatory cancer, represent examples of how useful large genetic screenings can be for understanding the tumorigenesis process and the future directions in the molecular pathogenesis of endometrian cancer.